RTW Venture Fund Limited Net Asset Value(s) (1415S)
12 Noviembre 2021 - 1:00AM
UK Regulatory
TIDMRTW
RNS Number : 1415S
RTW Venture Fund Limited
12 November 2021
LEI: 549300Q7EXQQH6KF7Z84
12 November 2021
RTW Venture Fund Limited
Net Asset Value
RTW Venture Fund Limited (the "Company") announces that the
unaudited net asset value attributable to the ordinary shares of
the Company at the close of business on 31 October 2021 (the "NAV")
was US$385.4 million, or US$1.82 per ordinary share.
As at 31 October 2021, 25.8 per cent. of the total NAV was
invested in privately-held core portfolio companies and 41.6 per
cent. of the total NAV was invested in public core portfolio
companies, most of which were initiated as private investments.
For Further Information
RTW Investments, LP +1 (646) 343 9280
Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Senior Business Development Associate
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
Morgan Stanley Fund Services USA LLC +1 (914) 225 8885
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
Barclays +44 (0)20 7623 2323
Tom Swerling
Andrew Tusa
Note :
1. The NAV is determined by the Company's investment manager,
RTW Investments, LP, in accordance with the Company's
accounting policies. Investments by the Company in privately-held
companies ("Private Portfolio Companies") have been valued
at fair market value, taking into account the valuation
prepared by Alvarez & Marsal Valuation Services LLC and
the nature, facts and circumstances of the Private Portfolio
Companies. Investments by the Company in companies listed
on a public stock exchange (the "Public Portfolio Companies")
have each been valued by reference to their market capitalisation
as at close of business on 30 September 2021. The Company
applies a valuation discount to its investments in Public
Portfolio Companies that are subject to post-IPO lock-up
provisions.
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG ) is an investment
fund focused on identifying transformative assets with high growth
potential across the biopharmaceutical and medical technology
sectors. Driven by a long-term approach to support innovative
businesses, RTW Venture Fund invests in companies developing
next-generation therapies and technologies that can significantly
improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a
leading healthcare-focused entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NAVGPGRGGUPGGQG
(END) Dow Jones Newswires
November 12, 2021 02:00 ET (07:00 GMT)
Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
